TYRA
Tyra Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.20B
P/E Ratio
—
EPS
$-2.01
Beta
0.96
52W High
$40.65
52W Low
$8.75
50-Day MA
$35.40
200-Day MA
$22.35
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tyra Biosciences Inc
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes for cancer patients. The company is headquartered in Carlsbad, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-132.22M |
| Operating Margin | 0.00% |
| Return on Equity | -39.80% |
| Return on Assets | -25.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.83 |
| Price-to-Book | 8.47 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -6.95 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $59.48M |
| Float | $28.38M |
| % Insiders | 2.69% |
| % Institutions | 93.89% |
Historical Volatility
HV 10-Day
52.61%
HV 20-Day
57.39%
HV 30-Day
52.95%
HV 60-Day
52.56%
HV Rank
21.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($51.24 target)
2
Strong Buy9
BuyData last updated: 4/28/2026